Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests […]

Why isn’t Pfizer’s COVID vaccine OK’d yet? White House calls in FDA chief Hahn to explain: Axios esagonowsky […]

Halozyme scores $190M Horizon deal to develop subQ Tepezza formula fkansteiner Tue, 12/01/2020 – 09:24

FDA goes beyond the label to educate doctors—and enlighten others—about new cancer drugs bbulik Tue, 12/01/2020 – 09:28

Indivior faces lawsuit from ex-parent company RB over Suboxone marketing scheme kblankenship Tue, 12/01/2020 – 11:05

Bacterial infections have become one of the biggest health problems worldwide, and a recent study shows that COVID-19 […]

Researchers from Bochum, Göttingen, Duisburg and Cologne have developed a new method for detecting bacteria and infections. They […]

An independent commission has called on the UK government to end new HIV transmissions by 2030 and normalise […]

Exact details of the £542.9m (€605.8m; $725m) that drug companies spent on healthcare organisations and healthcare professionals in […]

Grünenthal will pay $320m upfront for the rights